Huang Xi Wei - Net Worth and Insider Trading
Huang Xi Wei Net Worth
The estimated net worth of Huang Xi Wei is at least $861 Million dollars as of 2024-06-23. Huang Xi Wei is the Director of Nanjing King-Friend Biochemical Pharmaceutical Co Ltd and owns about 70,654,217 shares of Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) stock worth over $861 Million. Details can be seen in Huang Xi Wei's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Huang Xi Wei has not made any transactions after 2022-07-11 and currently still holds the listed stock(s).
Transaction Summary of Huang Xi Wei
Huang Xi Wei Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Huang Xi Wei owns 1 companies in total, including Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) .
Click here to see the complete history of Huang Xi Wei’s form 4 insider trades.
Insider Ownership Summary of Huang Xi Wei
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SHSE:603707 | Nanjing King-Friend Biochemical Pharmaceutical Co Ltd | 2022-07-11 | Director |
Huang Xi Wei Latest Holdings Summary
Huang Xi Wei currently owns a total of 1 stock. Huang Xi Wei owns 70,654,217 shares of Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) as of July 11, 2022, with a value of $861 Million.
Latest Holdings of Huang Xi Wei
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SHSE:603707 | Nanjing King-Friend Biochemical Pharmaceutical Co Ltd | 2022-07-11 | 70,654,217 | 12.19 | 861,274,905 |
Holding Weightings of Huang Xi Wei
Huang Xi Wei Form 4 Trading Tracker
According to the SEC Form 4 filings, Huang Xi Wei has made a total of 18 transactions in Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) over the past 5 years, including 0 buys and 16 sells. The most-recent trade in Nanjing King-Friend Biochemical Pharmaceutical Co Ltd is the sale of 16,304,819 shares on July 11, 2022, which brought Huang Xi Wei around $0.
Insider Trading History of Huang Xi Wei
- 1
Huang Xi Wei Trading Performance
GuruFocus tracks the stock performance after each of Huang Xi Wei's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Huang Xi Wei is 24.01%. GuruFocus also compares Huang Xi Wei's trading performance to market benchmark return within the same time period. The performance of stocks bought by Huang Xi Wei within 3 months outperforms 14 times out of 26 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Huang Xi Wei's insider trading performs compared to the benchmark.
Performance of Huang Xi Wei
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 16.36 | | | | | |
| Relative Return to S&P 500(%) | 13.41 | | | | | |
Huang Xi Wei Ownership Network
Huang Xi Wei Owned Company Details
What does Nanjing King-Friend Biochemical Pharmaceutical Co Ltd do?
Who are the key executives at Nanjing King-Friend Biochemical Pharmaceutical Co Ltd?
Huang Xi Wei is the Director of Nanjing King-Friend Biochemical Pharmaceutical Co Ltd. Other key executives at Nanjing King-Friend Biochemical Pharmaceutical Co Ltd include Supervisors Liu Zu Qing , senior management Wu Gui Ping , and senior management Qian Xiao Jie .
Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nanjing King-Friend Biochemical Pharmaceutical Co Ltd Insider Transactions
Huang Xi Wei Mailing Address
Above is the net worth, insider trading, and ownership report for Huang Xi Wei. Currently GuruFocus does not have mailing address information for Huang Xi Wei.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
